08:24 AM EDT, 03/24/2025 (MT Newswires) -- Alcon ( ALC ) said Monday it is planning to acquire Lensar ( LNSR ) for a total consideration of about $430 million.

Under the terms of the deal, Alcon ( ALC ) will purchase all outstanding shares of Lensar ( LNSR ) for $14 per share in cash, with an additional non-tradeable contingent value right offering up to $2.75 per share in cash, conditioned on the achievement of 614,000 cumulative procedures with Lensar's ( LNSR ) products between Jan. 1, 2026, and Dec. 31, 2027.

The acquisition includes the Ally Robotic Cataract Laser Treatment System, Streamline software technology, and Lensar's ( LNSR ) legacy laser system.

The transaction is expected to close in mid-to-late 2025.